Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Next/Generation Psychedelics

Recent news which mentions Next/Generation Psychedelics

Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
Tickers ENVB
Tags Market News Cannabis ENVB
From Benzinga
Fed Agency Grants $14M To Gilgamesh For Cardiac-Safe Ibogaine Analog Targeting Opioid Use Disorder
Tickers NEWS
Tags Benzinga Psychedelic/Assisted Therapies Cannabis
From Benzinga
Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next?
Tickers CYBN
Tags News CYBN Management
From Benzinga
Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice
Tickers CMND
Tags Benzinga Psychedelic/Assisted Therapies Stock Split
From Benzinga
Enveric Biosciences' Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical Trials
Tickers ENVB
Tags Markets ENVB Earnings
From Benzinga
Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026
Tickers ATAI CMPS
Tags Penny Stocks Psychedelic/Assisted Therapies Benzinga
From Benzinga
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
Tickers MSSTF
Tags Market News Cannabis Global
From Benzinga
Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program
Tickers CMND
Tags Cannabis Market News Benzinga
From Benzinga
Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions
Tickers CYBN DMTTF MSSTF NUGL
Tags Psychedelics Otsuka Pharmaceutical Co Next/Generation Psychedelics
From Benzinga
Boosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety Treatment
Tickers ENVB
Tags United States Patent and Trademark Office (USPTO) Markets ENVB
From Benzinga
Psychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen Library
Tickers CYBN
Tags CYBN Management Legal
From Benzinga
Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024
Tickers ENVB
Tags Legal Management News
From Benzinga
Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound
Tickers DRUG
Tags News clinical trials Markets
From Benzinga
Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details
Tickers REUN
Tags Guidance Markets Management
From Benzinga
Terran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Application
Tickers MSSTF REUN
Tags Legal Management News
From Benzinga
Reunion Neuroscience On The Brink Of Going Private With Final Court Approval
Tickers FTHWF MSSTF REUN
Tags Markets Management REUN
From Benzinga
Pioneering Psychedelics Scientist Alexander "Sasha" Shulgin's Legacy Lives On Via New Compounds And Research
Tags News Interview Management
From Benzinga
This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches
Tickers LOBEF
Tags Market News Chronic Cluster Headaches Cannabis
From Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
Tickers BETRF PHRRF
Tags News Markets Guidance
From Benzinga
Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor
Tickers CYBN
Tags Benzinga FDA Psychedelic/Assisted Therapies
From Benzinga
UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression
Tickers MSSTF
Tags MSSTF News Management
From Benzinga
Canadian Financing: PharmAla Biotech Offers Non-Brokered Private Placement Up To $3.76M
Tickers PMBHF
Tags Psychedelics Financing Market News Cannabis
From Benzinga
Mydecine's Prospectus Supplement Closing Under Share Subscription And Management Update
Tickers MYCOF
Tags Penny Stocks Benzinga Psychedelics Financing
From Benzinga
This Company's Psilocybin-Based Non Hallucinogenic Compound Heads Toward Clinical Studies
Tags Cannabis Markets Market News
From Benzinga
Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed
Tickers HUGE
Tags Market News multiple sclerosis Cannabis
From Benzinga
Delix's Non-Hallucinogenic Psychoplastogen Enters Phase 1 Trial
Tags News Psychoplastogens Next/Generation Psychedelics
From Benzinga
NY Biotech Gets International IP Coverage For Growing Portfolio Of Psychedelic-Derived Novel Drugs
Tags Psychedelic/Assisted Therapies Benzinga Market News
From Benzinga
This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection
Tickers MSSTF
Tags MSSTF News intellectual property
From Benzinga
Stress, Anxiety, PTSD: 2 NASDAQ-Listed Drug Developers Advance Psychedelic-Inspired Meds
Tickers DRUG SILO
Tags News anxiety disorders Management
From Benzinga
Are Next-Gen Psychedelics The Incoming Solution For Mental Health? Learn It All At Benzinga's Psychedelics Capital Conference
Tags Biotech Psychedelics Benzinga Psychedelics Capital Conference
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.